Adaption and preliminary validation of the Addenbrooke's Cognitive Examination-III as a screening test for mild cognitive impairment and dementia in hearing-impaired individuals

被引:6
|
作者
North, Courtney [1 ]
Heatley, Mary H. [1 ]
Utoomprurkporn, Nattawan [2 ,3 ]
Bamiou, Doris Eva [2 ,4 ]
Costafreda, Sergi G. [5 ]
Stott, Joshua [1 ]
机构
[1] UCL Div Psychol & Language Sci, Fac Brain Sci, 1-19 Torrington Pl, London WC1E 7HB, England
[2] UCL Ear Inst, London, England
[3] Chulalongkorn Univ, Fac Med, Bangkok, Thailand
[4] NIHR Biomed Res Ctr Hearing & Deafness, London, England
[5] UCL Div Psychiat, Maple House, London, England
关键词
dementia; cognitive screening; Addenbrooke' s Cognitive Examination; hearing loss; HI‐ ACE‐ III; MCI; mild cognitive impairment; COMPARATIVE DIAGNOSTIC-ACCURACY; DIFFERENTIAL-DIAGNOSIS; ALZHEIMERS-DISEASE; OLDER-ADULTS; ACE-III; LANGUAGE; MOCA; PREVALENCE; VALIDITY; UTILITY;
D O I
10.1111/ene.14753
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background A large proportion of older adults assessed for cognitive impairment likely have hearing loss, potentially affecting accuracy of cognitive performance estimations. This study aimed to develop a hearing-impaired version of the Addenbrooke's Cognitive Examination-III (HI-ACE-III) and to assess whether the HI-ACE-III can accurately distinguish people with mild cognitive impairment (MCI) and dementia from cognitively intact controls. Methods The HI-ACE-III was developed by converting verbal instructions into a visual, timed PowerPoint presentation. Seventy-four participants over the age of 60 years were classified into three groups: 29 had MCI, 15 had mild to moderate dementia and 30 were cognitively intact controls. Receiver operating characteristic (ROC) curves were graphed to test screening accuracy. Concurrent validity was examined through correlations between HI-ACE-III domain scores and relevant, visually presented standardized neuropsychological measures. Results ROC analysis for dementia revealed an area under the curve (AUC) of 0.99, achieving excellent sensitivity (100%) and good specificity (93.3%) at an optimum cut-off of <87. The AUC for MCI was 0.86, achieving reasonable sensitivity (75.9%) and good specificity (86.7%) at an optimum cut-off of <92. HI-ACE-III subtests shared anticipated and statistically significant correlations with established measures of cognitive functioning. Internal consistency of the HI-ACE-III was excellent as verified with Cronbach's alpha (alpha = 0.904). Conclusions Preliminarily, the HI-ACE-III showed good reliability, validity and screening utility for MCI and dementia in older adults in a hearing-impairment context. The adapted HI-ACE-III may offer accurate and reliable indication of cognitive performance, supporting timely diagnosis and research examining links between hearing loss and cognitive decline.
引用
收藏
页码:1820 / 1828
页数:9
相关论文
共 50 条
  • [1] Validation of the Addenbrooke's Cognitive Examination-III in Mild Cognitive Impairment in Arabic Speakers in Egypt
    Qassem, Tarik
    Khater, Mohamed S.
    Emara, Tamer
    Rasheedy, Doha
    Tawfik, Heba M.
    Mohammedin, Ahmed S.
    Tolba, Mohammad F.
    Saber, Heba G.
    El-Gabry, Dina Aly
    Aziz, Karim Abdel
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2021, 49 (04) : 418 - 422
  • [2] Adaptation and Validation of Addenbrooke's Cognitive Examination-III in Bengali for Screening MCI and Dementia
    Bhattacharyya, Bidisha
    Mukherjee, Ruchira
    Mukherjee, Adreesh
    Das, Gautam
    Dogra, Atanu Kumar
    Das, Sujata
    Biswas, Atanu
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2022, 37 (07) : 1619 - 1627
  • [3] Validation of the Portuguese version of Addenbrooke's Cognitive Examination III in mild cognitive impairment and dementia
    Peixoto, Bruno
    Machado, Milene
    Rocha, Patricia
    Macedo, Carla
    Machado, Antonio
    Baeta, Elia
    Goncalves, Gerly
    Pimentel, Paulo
    Lopes, Emanuela
    Monteiro, Luis
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (06): : 781 - 786
  • [4] Validation of Addenbrooke’s cognitive examination III for detecting mild cognitive impairment and dementia in Japan
    Shintaro Takenoshita
    Seishi Terada
    Hidenori Yoshida
    Megumi Yamaguchi
    Mayumi Yabe
    Nao Imai
    Makiko Horiuchi
    Tomoko Miki
    Osamu Yokota
    Norihito Yamada
    [J]. BMC Geriatrics, 19
  • [5] Validation of Addenbrooke's cognitive examination III for detecting mild cognitive impairment and dementia in Japan
    Takenoshita, Shintaro
    Terada, Seishi
    Yoshida, Hidenori
    Yamaguchi, Megumi
    Yabe, Mayumi
    Imai, Nao
    Horiuchi, Makiko
    Miki, Tomoko
    Yokota, Osamu
    Yamada, Norihito
    [J]. BMC GERIATRICS, 2019, 19 (1)
  • [6] Addenbrooke's Cognitive Examination-III
    Noone, Peter
    [J]. OCCUPATIONAL MEDICINE-OXFORD, 2015, 65 (05): : 418 - 420
  • [7] Validation of the Malay Version of Addenbrooke's Cognitive Examination III in Detecting Mild Cognitive Impairment and Dementia
    Kan, Kwai Ching
    Subramaniam, Ponnusamy
    Shahrizaila, Nortina
    Kamaruzzaman, Shahrul Bahyah
    Razali, Rosdinom
    Ghazali, Shazli Ezzat
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2019, 9 (01): : 66 - 76
  • [8] Validation Study of the Chinese Version of Addenbrooke's Cognitive Examination III for Diagnosing Mild Cognitive Impairment and Mild Dementia
    Li, Xiaojia
    Yang, Lili
    Yin, Jia
    Yu, Nengwei
    Ye, Fang
    [J]. JOURNAL OF CLINICAL NEUROLOGY, 2019, 15 (03): : 313 - 320
  • [9] A Validation Study of the Chinese Version of the Mini-Addenbrooke's Cognitive Examination for Screening Mild Cognitive Impairment and Mild Dementia
    Yang, Lili
    Li, Xiaojia
    Yin, Jia
    Yu, Nengwei
    Liu, Jie
    Ye, Fang
    [J]. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2019, 32 (04) : 205 - 210
  • [10] Validation of the Chinese version of Addenbrooke's cognitive examination III for detecting mild cognitive impairment
    Pan, Feng-Feng
    Wang, Ying
    Huang, Lin
    Huang, Yue
    Guo, Qi-Hao
    [J]. AGING & MENTAL HEALTH, 2022, 26 (02) : 384 - 391